Stem Cell Therapy for Knee Pain: Who It Helps and Who It Does Not

If your knee aches climbing stairs, swells after a walk, or has slowly stopped cooperating with the activities you used to take for granted, you have probably come across stem cell therapy in your search for answers. Online, it is sometimes described as a near-universal fix for knee pain. In reality, it helps some people meaningfully and is a poor fit for others, and the honest answer depends on specifics that only an exam and imaging can reveal. This article walks through what the therapy actually is, how it is thought to work, and the factors a physician weighs when deciding whether it belongs in your care plan.

What stem cell therapy for the knee actually is

At Utah Stem Cells, the cells used for joint injections come from donated umbilical cord and amniotic tissue — screened, laboratory-processed allogeneic material. They are not harvested from your own bone marrow or fat, and this clinic does not use autologous stem cells for joint treatment. That distinction matters because “stem cell therapy” is marketed inconsistently across the industry: some clinics draw cells from the patient’s own body through a surgical harvesting step, while others, like stem cell joint regeneration here, use donor-derived tissue that arrives already processed, so there is no harvesting procedure for the patient to undergo.

It is also worth separating stem cell therapy from PRP joint treatment, which is a different product entirely. PRP (platelet-rich plasma) is autologous — it comes from your own blood, concentrated and re-injected — while the stem cell preparation is donor-sourced. The two are sometimes discussed together, and our article on PRP vs. stem cells for joint pain goes into more depth on when each is considered.

How it is thought to work

The cells and the growth factors they carry are intended to modulate inflammation inside the joint and support a more favorable healing environment. This is not the same claim as “regrowing cartilage” or reversing arthritis — that language oversells what the current evidence supports. The more accurate framing, and the one we use with patients, is that the injection may help calm an inflamed joint and support function, with results that vary from person to person. For background on how researchers are studying this mechanism in knee osteoarthritis, see our summary of stem cell research on knee osteoarthritis.

Who tends to be a reasonable candidate

Across clinical literature and physician experience, a few patterns show up repeatedly in people who are more likely to see meaningful benefit:

• Early-to-moderate joint changes. Patients with mild to moderate osteoarthritis — where cartilage is thinned but not entirely gone and the joint space is still at least partially preserved on imaging — tend to respond more predictably than those with advanced, bone-on-bone disease.
• One joint or a clearly localized problem, rather than widespread, poorly defined pain across multiple areas of the body.
• Good overall health, without uncontrolled autoimmune disease, active infection, or a significant untreated systemic illness that would complicate healing.
• Realistic goals. Candidates who understand this is a supportive, non-curative option — not a replacement for surgery when surgery is truly indicated — tend to be more satisfied with the outcome, whatever it turns out to be.
• A documented history of the condition, including prior imaging and, often, prior conservative treatments such as physical therapy, bracing, or anti-inflammatory management that have not fully resolved the pain.

If several of these apply to you, it is reasonable to ask a physician whether an evaluation makes sense. Our guide on who is a good candidate for stem cell joint therapy covers the intake process in more detail.

Who is usually not a good fit

Equally important is recognizing when this is not the right tool. A physician is likely to advise against it, or to recommend a different path first, for patients who have:

• Severe, end-stage joint collapse with little to no remaining cartilage or joint space, where a mechanical problem is better addressed by an orthopedic surgeon.
• Significant deformity or instability in the knee, such as advanced bowing or ligament laxity that the injection cannot correct.
• Active infection, uncontrolled autoimmune flares, certain blood disorders, or an unmanaged systemic illness, any of which can make an injection unsafe or unpredictable.
• An expectation of a cure. If the goal is to permanently reverse arthritis or avoid ever needing further care, that expectation does not match what regenerative injections are shown to do.
• Pain that is not actually coming from the joint — referred pain from the back or hip, for instance, will not improve with a knee injection, which is why an accurate diagnosis matters before any procedure.

If any of these describe your situation, that does not mean you are out of options — it means the conversation should start with a different treatment, or with surgical referral, rather than an injection.

How it compares to other paths

Patients weighing this decision are usually also considering a cortisone shot, PRP, or, at the more advanced end, knee replacement. Our article on stem cells vs. cortisone for knee arthritis reviews what a large, controlled trial found when the two were compared head-to-head — the short version is that neither is a knockout winner on pain relief alone, and the choice often comes down to mechanism, injection frequency, and personal priorities rather than a clear “best” option. For patients specifically trying to understand whether this kind of injection can help them postpone or avoid surgery, can you avoid knee replacement with stem cells walks through that question directly, including the cases where replacement is still the right call.

What to expect from an evaluation at Utah Stem Cells

Every patient starts with a physician evaluation, not a sales pitch. Dr. William Cimikoski or a member of the clinical team reviews your history, current imaging if available, and prior treatments before discussing whether a regenerative option is appropriate — and if it is not, saying so plainly. If imaging is outdated or missing, new imaging may be recommended first. Eligibility is determined by the physician after this individualized review, not by a general checklist applied to everyone who calls.

This is also where cost comes up, since it is a real factor in the decision. Stem cell therapy is priced at $6,000 for the first treatment and $2,200 for each subsequent treatment, whether that follow-up treats the same joint or a different one. These figures are discussed in the context of your specific plan, after the physician has confirmed that the therapy is a reasonable option for your knee.

Frequently asked questions

Where do the stem cells come from?

They come from donated umbilical cord and amniotic tissue, screened and processed in a laboratory. Utah Stem Cells does not use stem cells taken from your own bone marrow or fat for joint therapy. You can read more about why donor tissue is used instead of your own in umbilical cord stem cells: why donated tissue, not your own.

Is stem cell therapy FDA-approved for knee pain?

No. It is not an FDA-approved cure for arthritis or knee pain, and no clinic should claim otherwise. Our article on is stem cell therapy FDA-approved explains the current regulatory landscape so you can ask informed questions.

How much does it cost?

Stem cell therapy is $6,000 for the first treatment and $2,200 for each treatment after that, for the same or a different area. Final eligibility and the recommended plan are determined by the physician after your evaluation — cost is discussed alongside that clinical decision, not instead of it.

Will it regrow my cartilage or cure my arthritis?

No. The honest framing is that it may help modulate inflammation and support joint function; it is not a regrowth therapy or a cure, and results vary between patients. Anyone promising guaranteed cartilage regeneration is overstating the evidence.

How is this different from PRP?

PRP uses your own blood, concentrated and re-injected (autologous). The stem cell preparation used here comes from donated tissue (allogeneic). They work through different mechanisms and are sometimes used as part of the same broader plan. See PRP vs. stem cells for joint pain for a side-by-side look.

What if I am not a candidate?

If your knee has advanced bone-on-bone changes, significant instability, or an active medical issue that rules out injections, the physician will say so and discuss alternatives, which may include physical therapy, PRP, or a referral for surgical evaluation. A clear “not now” or “not this” is a legitimate outcome of an honest evaluation.

This article is for general education and does not constitute medical advice or a promise of any particular result. Stem cell therapy for knee pain is not an FDA-approved cure for arthritis, individual results vary, and candidacy is determined only after an individualized evaluation by a physician. Speak with a qualified provider before making any treatment decision.